We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

42 hedge funds and large institutions have $104M invested in Applied Genetic Technologies Corporation in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 6

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

40% more capital invested

Capital invested by funds: $74.3M → $104M (+$29.7M)

11% more funds holding

Funds holding: 3842 (+4)

Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
1.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
24
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change

AGTC Hedge Fund Activity: Q3 2014 in Review

42 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2014, worth a combined $104M — up 40% from $74.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AGTC positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 6 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $8.81M. The largest seller was Cormorant Asset Management, cutting an estimated $2.86M.

  • 42 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2014, up from 38 in Q2 2014.
  • Funds reported $104M of Applied Genetic Technologies Corporation stock for Q3 2014, up 40% quarter-over-quarter.
  • 9 funds opened new Applied Genetic Technologies Corporation positions in Q3 2014 and 5 closed out, a net change of +4 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q3 2014 was Point72 Asset Management, an estimated $8.81M added.
  • The largest Applied Genetic Technologies Corporation seller in Q3 2014 was Cormorant Asset Management, an estimated $2.86M sold.

Based on aggregated 13F filings for Q3 2014.